Evidence map›Paper›PMID 24570108›Full record

ArticleDer Radiologe2014

[Future of mammography-based imaging].

R Schulz-Wendtland, T Wittenberg, T Michel, A Hartmann, M W Beckmann, C Rauh, S M Jud, B Brehm, M Meier-Meitinger, G Anton and 2 more

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Der Radiologe, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

R Schulz-WendtlandGynäkologische Radiologie, Radiologisches Institut, Klinikum der Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätstr. 21-23, Erlangen, Deutschland, ruediger.schulz-wendtland@uk-erlangen.de.
T Wittenberg
T Michel
A Hartmann
M W Beckmann
C Rauh
S M Jud
B Brehm
M Meier-Meitinger
G Anton
M Uder
P A Fasching
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEComprehensive Cancer Center Erlangen · DEFraunhofer Institute for Integrated Circuits · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammography is the central diagnostic method for clinical diagnostics of breast cancer and the breast cancer screening program. In the clinical routine complementary methods, such as ultrasound, tomosynthesis and optional magnetic resonance imaging (MRI) are already combined for the diagnostic procedure. Future developments will utilize investigative procedures either as a hybrid (combination of several different imaging modalities in one instrument) or as a fusion method (the technical fusion of two or more of these methods) to implement fusion imaging into diagnostic algorithms. For screening there are reasonable hypotheses to aim for studies that individualize the diagnostic process within the screening procedure. Individual breast cancer risk prediction and individualized knowledge about sensitivity and specificity for certain diagnostic methods could be tested. The clinical implementation of these algorithms is not yet in sight.

Indexed as

ForecastingAlgorithmsBreast NeoplasmsEarly Detection of CancerFemaleHumansImage EnhancementMammographyMolecular ImagingMultimodal ImagingSubtraction Technique

Identifiers

PMID24570108
OpenAlexW140171461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.